Search

Displaying results 6211 - 6220 of 9670 in total
  1. Drug

    Trotabresib

    go.drugbank.com/drugs/DB17421
    Investigational

    Trotabresib is an oral, potent, and reversible inhibitor of the epigenetic target bromodomain and extra-terminal (BET) proteins.

    Synonyms: Bet inhibitor cc-90010
  2. Drug

    Agerafenib

    go.drugbank.com/drugs/DB15068
    Investigational

    Agerafenib is under investigation in clinical trial NCT03052569 (Expanded Access to RXDX-105 for Cancers With RET Alterations).

  3. Drug

    EC-0652

    go.drugbank.com/drugs/DB15340
    Experimental

    EC-0652 is under investigation in clinical trial NCT02202447 (Phase 1 of EC1169 In Patients With Recurrent MCRPC).

  4. Drug

    Adipiplon

    go.drugbank.com/drugs/DB06579
    Investigational

    It is known by the standardized identifier NG2-73.

  5. Drug

    Sparsomycin

    go.drugbank.com/drugs/DB04222
    Experimental

    It inhibits protein synthesis in 70S and 80S ribosomal systems. [PubChem]

  6. Drug

    Gusperimus

    go.drugbank.com/drugs/DB12692
    Investigational

    Gusperimus has been used in trials studying the treatment of Lupus Nephritis, Wegeners Granulomatosis, and Wegener's Granulomatosis.

  7. Drug

    Enfenamic acid

    go.drugbank.com/drugs/DB19487
    Experimental

    Enfenamic acid has a monoisotopic molecular weight of 241.11 Da.

  8. Drug

    Sorbitan monooleate

    go.drugbank.com/drugs/DB19493
    Experimental

    Sorbitan monooleate has a monoisotopic molecular weight of 428.31 Da.

  9. Drug

    Propyl docetrizoate

    go.drugbank.com/drugs/DB19514
    Experimental

    Propyl docetrizoate has a monoisotopic molecular weight of 640.81 Da.

  10. Drug

    Nafcaproic acid

    go.drugbank.com/drugs/DB19520
    Experimental

    Nafcaproic acid has a monoisotopic molecular weight of 242.13 Da.